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Abstract The macula is a unique and important region in
the primate retina that achieves high resolution and color
vision in the central visual field. We recently reported data
obtained from microarray analysis of gene expression in the
macula of the human fetal retina (Kozulin et al., Mol Vis
15:45–59, 1). In this paper, we describe the preliminary
analyses undertaken to visualize differences and verify
comparability of the replicates used in that study, report the
differential expression of other gene families obtained from
the analysis, and show the reproducibility of our findings in
several gene families by quantitative real-time PCR.
Keywords Macula.Geneexpression.Microarray.
Axonguidance.Angiogenesis.Celladhesionmolecules
Introduction
The macula is an anatomically and functionally distinct
region in the primate retina at the center of which is the
highly specialized fovea centralis, where there is a peak
density of cone photoreceptors. The high packing density of
inner and outer segments in the foveal cone mosaic enables
a high degree of spatial resolution that is preserved by the
“midget” bipolar/ganglion cell circuit. Good visual acuity,
however, is also dependent on a clear optical path for
incoming light. A lack of large blood vessels in the fovea
reduces shadowing of the foveal cone mosaic, avoiding
“angioscotomas” in the central visual field [2]. Previous
investigations of the developing human and monkey retinas
have found that during normal development the growth of
retinal blood vessels into the developing macular region is
“retarded” [3, 4]. We have also observed that astrocytes,
which lead the migration of vascular endothelial cells across
the retina, appear to strike a molecular “no-go” barrier that
prevents them from entering the foveal region during devel-
opment [5] and that as a result the foveal region in monkeys
and humans is not normally vascularized [5, 6].
Despite these evident specializations of both the neural
circuitry and the retinal vessels at the macula, both of which
are essential to its functionality, little is known about the
genes that generate and regulate the development and
maintenance of these features. To address this, we carried
out a microarray analysis of gene expression in the
developing human macula [1]. We reported the upregula-
tion of axon/vascular guidance genes and some negative
regulators of angiogenesis at the developing macula [1].
Here, we provide more information concerning the con-
straints involved when using rare tissue samples in this type
of study and the strategies we used to validate the data as
well as provide further analysis of the gene families we
found to be differentially regulated in the macula samples.
Materials and methods
Human retinas
Four human retinas were obtained at surgery for termina-
tion of pregnancy, with informed maternal consent and the
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Sydney and The Australian National University. A single
retina was obtained from each fetus aged 19–20 weeks’
gestation (WG). Gestational age was determined by
ultrasound prior to surgery and confirmed by postmortem
measurements of foot length. RNAwas extracted from three
sample locations in each retina—“macula,”“ nasal,” and
“surround” (Fig. 1)—between 90 and 120 min postmortem,
as described previously [1]. Due to the difficulties involved
in obtaining suitable donor retinas, we obtained the retinas
on two separate occasions; two were donated on one day in
2006 and another two on an occasion in 2007. Thus, six
cDNA samples (three samples from each of two retinas)
were hybridized to microarrays on two separate occasions,
i.e., in two “batches”—one in 2006 and another in 2007.
The ages of three of the donor retinas were estimated at
19 WG, while the fourth was estimated at 20 WG. These
ages are approximate and generally regarded as ±1 week.
Hybridization and preprocessing
Double-stranded cDNA was generated from each of the
samples and transcribed to obtain biotin-labeled cRNA.
These cRNAs were fragmented, combined with hybridiza-
tion and spike controls, and then hybridized to 12 HG-
U133 Plus 2.0 GeneChip® microarrays (Affymetrix, Inc.,
Santa Clara, CA, USA) for 16 h under controlled con-
ditions. Following hybridization, the arrays were washed,
stained, and scanned as described previously [1]. The
microarray dataset can be accessed in the NCBI Gene
Expression Omnibus repository ([7], accession number
GSE12621). The quality controls used have been described
previously [1]. Affymetrix CEL files were imported into
Partek® Genomics Suite™ 6.3 (Partek Inc., St. Louis, MO,
USA) using the default Partek normalization parameters.
Briefly, probe-level data were preprocessed, including
background correction, normalization, and summarization
using robust multiarray average (RMA) analysis, and adjusted
for probe sequence and GC content (GC-RMA). Adjusted
and normalized “perfect match” values were summarized
for each probe set to generate a single measure of
expression and then log-transformed, base 2. A two-way
analysis of variance (ANOVA) was used for differential
expression analysis; the ANOVA variables were the sample
region (macula, nasal, and surround) and hybridization
batch. A significance level of P<0.01 was used to measure
difference in gene expression.
“Batch effect” in the microarray dataset
Because the four donor retinas were collected and pro-
cessed in two separate batches, differences in sample
preparation, reagent lot, and GeneChip® lot had the
potential to introduce additional variables into the array
data (batch effect). We used two approaches to evaluate the
GC-RMA-processed data for batch effects. First, an
analysis of signal intensity, both within and between the
array batches, and second, filtering of the processed data to
visualize “hierarchical clusters” and to carry out principal
component analysis (PCA).
1. Signal intensity—density plots
Density plots were generated using the GC-RMA-
processed signal intensity data. “Within-batch (2006)”
variation at each of the three sample locations was
determined by comparing differences in probe set signal
intensity data in array 1 with array 2. Similarly, “within-
batch (2007)” variation was determined by comparing
signal intensity data in array 3 with array 4. “Interbatch
variation” was measured by comparing signal intensity data
across all four donor samples. The density plots were
generated using the kernel density estimation in R version
2.7.0 (The R Foundation for Statistical Computing, http://
www.r-project.org). Bandwidth (bin) size for each curve
was determined using the method of Silverman [8].
2. Filtering the batch effect
Visualization of the sample differences in the GC-RMA-
processed data was achieved by filtering, using Partek
Fig. 1 Drawing of a 20 WG human retina, showing the patterning of
retinal axons (gray) and of the retinal vessels (red). The position of the
developing fovea is indicated. The circles indicate the approximate
size and locations of the nasal and macula tissue samples excised for
RNA extraction and differential gene expression analysis. The retina
remaining after the nasal and macula biopsies were removed was used
as the third sample region (surround tissue sample). Notice that the
macula region is avascular, compared with the nasal region, even
though the two sample areas are equidistant from the optic disk
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ANOVA to estimate the effects of batch and adjusts the data
to render the batches as equivalent. Because the batch effect
filter processes the data in a similar manner to the ANOVA,
which is integral to subsequent data processing, we used
this approach to obtain a view of the clustering of gene
expression profiles in our samples. We used two methods of
visualization—“hierarchical clustering” and “principal
component analysis.”
Hierarchical clustering
We used the agglomerative clustering method, whereby
the two most similar items are combined at each stage.
Once the first cluster is formed, the next two most similar
items/clusters are combined; this pattern of combination
is reiterated until all objects are clustered. Interobject/
cluster distance and dissimilarity were measured using
average linkage and the Euclidean distance metric, re-
spectively. Objects that are very similar are, thus, com-
bined with short dendrogram branches, while relatively
dissimilar groups are indicated by elongated dendrogram
branches.
Principal component analysis
PCA is a method of reducing the number of observed
variables in a dataset to a smaller number of principal
components (PC) that account for most of the observed
variance. PCA reduces the dimensionality of the dataset
into n PC, where n equals the number of datasets—in this
case, the number of arrays is n=12. The PC are ordered by
the amount of variance explained—such that the first PC
accounts for the largest amount of variance and the 12th for
the smallest amount—and are uncorrelated. The variances
of the PC are given by the eigenvalues, and the rotations of
the PC are given by the eigenvectors [9, 10]. We used
Partek software for PCA, using normalized eigenvector
scaling and a correlation dispersion matrix.
Quantitative real-time PCR
Microarray differential gene expression results were veri-
fied using quantitative real-time polymerase chain reaction
(QRT-PCR). The detailed protocols for cDNA synthesis,
primer design, and equipment and settings have been
described previously [1]. Product amplification was mea-
sured using either an Invitrogen (Carlsbad, CA, USA)
SYBR® Green-based kit (individual reagents or premade
master mixes) or Taqman® probes (Applied Biosystems,
Melbourne, Australia). We used cDNA from human fetal
retinas aged between 17 and 20 WG as template. Each
QRT-PCR reaction volume was 20 µl with 0.4 µl cDNA,
except reactions made with SYBR® Green ER™ supermix
which contained a 25-µl reaction volume with 0.5 µl
cDNA. Taqman reactions were performed in triplicate with
template from three different specimens. Because of the
limited availability of human fetal mRNA, some QRT-PCR
reactions were run in triplicate using template from only
one or two specimens. Amplification was normalized
relative to a glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) reference gene and analyzed with the Pfaffl [11]
method of relative quantification. GAPDH was amplified
using custom primers (SYBR Green) or a Taqman probe
according to the amplification system used for each run.
The specificity of amplification was determined by melt
curve analysis (SYBR Green) or 1% agarose gel electro-
phoresis (Taqman). Primers and Taqman probes used for
genes that we have not reported previously are listed in
Tables 1 and 2, respectively.
Table 1 QRT-PCR primers
NCBI RefSeq Gene Forward primer (5′–3′) Reverse primer (5′–3′)
NM_005191 CD80 GACAACCAACCACAGCTTCA GATGGGAGCAGGTTATCAGG
NM_001963 EGF CAGTCACACTGGTTTGGTCAG ACCACGCCAATGAGGAGTTA
NM_005249 FOXG1B GTCAATGACTTCGCAGAGCA AATCAGACAGTCCCCCAGAC
NM_002046 GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG
NM_005459 GUCA1C ATGATGCTGATGGAAATGGTT CTCAGAGTTTGCTGGCCATT
NM_000513 OPN1MW AGCATCATCGTGCTCTGCTA CCTTCTGGGTGGATTCAGAC
NM_000954 PTGDS AACCAGTGTGAGACCCGAAC TCCACCACTGACACGGAGTA
NM_004787 SLIT2 CAGCCCTACTGTGAATGCAG TTGTTTGGCAAGCAGCATAG
NM_133369 UNC5A ACCCCGAGGGAAGATCTATG CCACAGCTAACGATGGGACT
CD80 CD80 molecule, EGF epidermal growth factor (beta-urogastrone), FOXG1B forkhead box G1, GAPDH glyceraldehyde-3-phosphate
dehydrogenase, GUCA1C guanylate cyclase activator 1C, OPN1MW opsin 1 (cone pigments) medium-wave sensitive, PTGDS prostaglandin D2
synthase 21 kDa (brain), SLIT2 slit homolog 2 (Drosophila), UNC5A unc-5 homolog A (C. elegans)
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We used the functional annotation tool on the Database for
Annotation,Visualization,andIntegratedDiscovery(DAVID)
website[12, 13] to cluster groups of genes highly represented
in the macula vs. surround and macula vs. nasal differential
expression gene lists. The genes were clustered according to
functional roles or “biological process” as specified by the
Gene Ontology Consortium [14] using an Expression
Analysis Systematic Explorer (EASE) score threshold of 0.1.
In the 19–20 WG retinas used in the current study, we
know that there are significant differences in cell function
between macular and nonmacular locations because it is well
documented that retinal differentiation proceeds in a cen-
troperipheral pattern, centered on the macula. By 19 WG, the
majority of cells in the macula have ceased mitosis and have
differentiated as neurons. In contrast, retinal progenitor cells
in nonmacular locations are still proliferating at 19 WG [15,
16]. The mature state of cells in the macula suggests that
biological processes related to metabolism, neurotransmis-
sion, and phototransduction would be differentially regu-
lated in the macula, relative to nonmacular regions. For this
reason, genes that clustered under those headings, together
withgenesthatregulatecellcycle andcellproliferation, were
excluded from further differential analyses. The remaining
list of genes was then subcategorized again according to
Gene Ontology Consortium biological processes using the
DAVID web tool and 0.1 EASE score threshold.
KEGG pathway and InterPro protein database analysis
The remaining gene lists were also subcategorized accord-
ing to the pathways described by the Kyoto Encyclopedia
of Genes and Genomes (KEGG) [17] and the InterPro
protein database [18]. The KEGG and InterPro databases
were consulted to determine the dominant molecular/reac-
tion pathways and dominant protein families/domains/
regions (respectively) that are represented in and encoded
by the differentially expressed genes. This additional
clustering was performed using the DAVID web tool and
0.1 EASE score threshold.
Results
Batch effect in the microarray dataset
1. Signal intensity—density plots
The frequency distributions of these differences are
shown in Fig. 2. Curves in red show differences in signal
Table 2 Taqman probes
Entrez
gene ID
Gene Taqman probe ID Amplicon
length
576 BAI2 Hs00184657_m1 68
2597 GAPDH Hs99999905_m1 122
91584 PLXNA4 Hs00326001_m1 89
7474 WNT5A Hs00180103_m1 101
BAI2 brain-specific angiogenesis inhibitor 2, GAPDH glyceraldehyde-
3-phosphate dehydrogenase, PLXNA4 plexin A4, WNT5A wingless-
type MMTV integration site family member 5A
Fig. 2 Density plots of interbatch and intrabatch signal intensity
variance. The red lines show the difference in signal intensity from the
arrays between specimens 1 and 2 (batch 1); the green lines show the
difference in signal intensity from the arrays between specimens 3 and
4 (batch 2), and the black lines show the difference in signal intensity
between the batches. The plots were normalized such that the area
under each curve is 1. The Y-axis shows normalized density or
frequency for each signal variance bin. Bin size ranged from 0.0127 to
0.0169. The peak of each curve indicates modal signal variance,
which is similar for each of the three comparisons in each sample
region. The peak values show minor differences in signal intensity
variance between arrays or between batches, indicating no need to
adjust for signal intensity levels between batches. Peak values ranged
between: a macular arrays, 0.042 and 0.046; b surround arrays, 0.030
and 0.044; c nasal arrays, 0.032 and 0.047
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differences in intensity between arrays 3 and 4, and curves
in black, the interbatch differences for macula (Fig. 2a),
surround (Fig. 2b), and nasal (Fig. 2c) samples. The data
indicate that, in all sample regions, the differences in signal
intensities are small and similar within and between
batches. That is, in all comparisons, the modal difference
in signal intensity ranged between 0.030 and 0.047. The
overwhelming majority of probe sets had very small
differences in signal intensity value.
2. Filtering the batch effect
Hierarchical clustering
Dendrograms obtained using Partek software showing the
clustering of gene expression profiles from the 12 samples
of human fetal retina are shown in Fig. 3. Figure 3a is a
dendrogram showing clustering of gene expression profiles
before application of the batch filter. Each of the two major
clusters in the dendrogram comprises samples from only
one batch (2006, specimens 1 and 2, or 2007, specimens 3
and 4). Within these major clusters, the macula samples
cluster separate from the nasal and surround samples, which
tend to cluster together. Analysis of the data adjusted for the
batch effect is shown in Fig. 3b. This dendrogram shows
two primary clusters, one entirely comprising macula
samples and the other comprising a combination of nasal
and surround samples. The data show that the gene
expression profiles in the four macula samples are more
similar to each other than to other locations of the same
donor retinas.
Principal component analysis
Results of the PC analysis are shown in Fig. 4. Typically,
only the first few PCs are visualized, since these account
for most of the variance in the data. Figure 4 shows plots of
the first three PC of the log-transformed GC-RMA-
processed data, on X–Y–Z axes, before (Fig. 4a) and after
(Fig. 4b) the batch effect filter was applied to the data. In
these plots, points near each other are similar, while points
far apart are different in a large number of variables. On the
plot, color indicates sample location, and shape indicates
specimen number. Figure 4a shows batch-induced separa-
tion of the six arrays prepared in 2006 (tetrahedrons and
cubes) to the right, with the six prepared in 2007
(octahedrons and spheres) grouping to the left. The
proportions of total variance explained by PC 1, 2, and 3
were 28.2%, 15.9%, and 9.0%, respectively.
PCA after correction of the data for the batch effect is
shown in Fig. 4b. This plot shows that the largest source of
variation in the gene expression data was sample location,
reflected in the tight aggregation of nasal and surround
samples to the right, along the X-axis (PC axis 1), and the
grouping of macula samples to the left. The macula sample
from specimen 4 is separated from the other macula
samples along the Y-axis (PC axis 2) but still groups more
Fig. 3 Hierarchical clustering of the microarray gene expression
profiles. The sample region (left column) and specimen (right column)
is indicated for each array in the dendrograms. a. Hierarchical
clustering before application of the batch effect filter. Clustering is
greatest between arrays within specimens and batch. The four most
similar pairs of arrays (shortest dendrogram branches) are the nasal
and surround arrays from each specimen. The greatest dissimilarity in
the dendrogram exists between the two batches (specimens 1 and 2
versus specimens 3 and 4) since the final (leftmost) cluster exists
between these two groups of arrays. b Hierarchical clustering after
application of the batch effect filter. The macula arrays exhibit greater
similarity with each other than with the nasal or surround arrays, even
from the same specimen
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nasal/surround samples along the X-axis. The proportions
of total variance explained by PC 1, 2, and 3 are 20.7%,
14.0%, and 12.2%, respectively.
Quantitative real-time PCR
Table 3 is a summary of differential gene expression results
prepared for parts of other studies [1, 19] (Kozulin et al.,
manuscript in preparation) and included here to demon-
strate consistency of the microarray differential expression
data, with differential expression levels quantified by QRT-
PCR. The data show good agreement between levels
measured by QRT-PCR and the microarray, particularly
where P<0.01 (probe sets not indicated*). Figure 5 shows
the results for other genes for which differential expression
is not reported elsewhere. QRT-PCR (dark gray bars) shows
strong consensus with the direction of modulation (upregu-
lation or downregulation) as well as the magnitude of
modulation for most of these genes.
Biological process clustering
Approximately 3,550 genes were found to be significantly
differentially regulated in the macula vs. surround and
macula vs. nasal comparisons, at P<0.01. Clustering of
these gene lists (DAVID database) generated a set of
biological process clusters (see [1], Table 4). Clusters of
genes associated with the differentiated state of the macula,
relative to the periphery, were identified (listed in Table 4)
and removed from the list of differentially expressed
macular genes, leaving approximately 1,850 genes in each
list of differentially expressed macular genes of interest.
These remaining genes of interest were reclustered accord-
ing to biological process, resulting in about 100 small gene
clusters, which were then consolidated into their parent
categories. Communication and regulatory processes fea-
ture prominently in this refined gene list. The ten most
highly represented of these biological processes are shown
in Table 5.
KEGG pathway and InterPro protein database analysis
The proportions of macular genes of interest that cluster
into highly represented KEGG pathways are shown in
Fig. 6. Pathways associated with axon guidance and regula-
tion of the actin cytoskeleton represent between 13% and
23% of the macular genes of interest. The remaining
clusters have roles in cell adhesion.
Gene clustering according to the InterPro protein
database resulted in 71 and 98 clusters from the macula
vs. surround and macula vs. nasal gene lists, respectively.
Fig. 4 Principal component analysis of the microarrays. Each data
point/shape represents a microarray, with all 12 arrays presented on
the PCA plot before (a) and after (b) the batch effect filter was
applied. Macula (red), nasal (blue), and surround (green) arrays are
distinguished by color, and specimens 1 (tetrahedron), 2 (cube), 3
(octahedron), and 4 (sphere) are distinguished by shape. Once the data
are adjusted for batch (b), macula arrays aggregate to the left and nasal
and surround arrays aggregate to the right of PC 1 (X-axis). The
macula array of specimen 4 shows some separation from the other
macula arrays along PC 2 (Y-axis). Given PC 1 describes the largest
amount of data variance (20.7%), the aggregation of the arrays is
mostly accounted for by sample location. The percentage values in
parentheses indicate the proportion of total variance described by each
PC. PC 1 principal component 1 (X-axis); PC 2 principal component 2
(Y-axis); PC 3 principal component 3 (Z-axis)
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Gene symbol Affymetrix
probe set ID
Macula vs. surround Macula vs. nasal
Microarray QRT-PCR Microarray QRT-PCR
P DE
a (%) SE
b (%) DE
a (%) SE
b (%) P DE
a (%) SE
b (%) DE
a (%) SE
b (%)
EFNA1 202023_at 0.317 – 17.28* 5.29 – 32.28 13.66 0.342 – 16.31* 17.05 – 45.60 12.55
EFNA2 1553573_s_at 0.130 – 
– 
7.34* 4.34
– 102.59 21.61
0.041 – 10.76* 5.93
– 40.97 12.05 EFNA2 208256_at 0.720   1.62* 3.65 0.900 0.56* 5.64
EFNA3 210132_at 0.062 8.52* 5.64 21.50 7.93 0.128 6.61* 4.89 – 22.83 1.91
EFNA4 205107_s_at 0.008 – 32.41 11.66 – 44.92 8.15 0.002 – 42.61 8.79 – 77.80 7.12
EPHA6 1561396_at 0.009 14.76 3.10
135.85
c 11.10
0.002 19.94 5.00
49.47
c 33.96 EPHA6 233184_at 0.344 4.47* 7.12 0.500 3.12* 4.30
EPHA6 233789_at 0.015 19.94* 9.78 0.005 25.66 7.08
FGF2 204421_s_at 0.016 – 29.52* 14.13 – 28.83 2.91 0.259 – 10.83* 7.80 – 31.59 22.92 FGF2 204422_s_at 0.818 – 1.71* 8.63 0.511   5.02* 12.76
NPPB 206801_at 0.003 28.57 9.04 59.89 17.17 0.002 33.05 12.05 90.63 13.00
NRP1 1561365_at 0.107 – 17.15* 14.05
–  22.91 9.36
0.040 – 23.74* 14.82
– 24.52 1.47
NRP1 210510_s_at 0.115 – 14.97* 4.60 0.031 – 22.97* 12.25
NRP1 210615_at 0.005 – 
– 
19.85 4.38 0.026 – 13.63* 3.83
NRP1 212298_at 0.005   39.47 10.15 0.002 – 49.84 14.98
NTNG1 206713_at 0.975 0.09* 3.94
87.99 9.29
0.063 6.43* 0.48
191.22 17.68 NTNG1 236088_at 0.006 92.48 40.81 <0.001 272.00 69.85
NTNG1 238133_at 0.043 104.87* 85.51 0.002 300.47 111.59
PEDF 202283_at 0.003 49.52 11.23 32.97 7.21 0.004 46.62 15.57 45.96 6.69
PLXNC1 206470_at 0.003 – 58.01 22.59
– 47.87 19.03
0.003 – 60.43 21.36
– 53.00 12.57
PLXNC1 206471_s_at <0.001 – 74.36 25.10 <0.001 – 67.57 12.18
PLXNC1 213241_at 0.040 – 34.73* 15.37 0.009 – 50.62 23.83
PLXNC1 235328_at 0.217 – 23.18* 37.14 0.075 – 
– 
37.41* 24.07
SEMA3D 215324_at 0.585 – 4.19* 10.91
78.31 10.22
0.562   4.47* 6.68
50.32 14.46 SEMA3D 215643_at <0.001 66.94 12.79 0.007 44.71 8.11
SEMA3G 219689_at 0.006 37.33 7.07 99.90 60.48 0.012 31.41* 8.00 91.58 61.04
SEMA4F 208124_s_at 0.921 0.91* 10.97
31.81 11.55
0.387 8.42* 7.38
34.26 5.25
SEMA4F 210124_x_at <0.001 39.00 6.43 <0.001 46.44 11.33
SEMA4F 211157_at 0.005 14.50 2.81 0.009 12.59 3.44
SEMA4F 228660_x_at 0.001 44.54 8.52 0.002 39.42 13.34
UNC5D 231325_at <0.001 166.40 57.85 145.82 17.83 <0.001 191.62 36.63 121.42 9.74
VEGFA 210512_s_at 0.767 –3.32* 7.86
5.61 4.87
0.832 2.36* 6.36
5.66 3.28
VEGFA 210513_s_at 0.179 – 29.49* 32.27 0.631 – 9.13* 15.39
VEGFA 211527_x_at 0.347 – 13.75* 13.19 0.878 – 2.06* 6.29
VEGFA 212171_x_at 0.558 – 7.54* 5.29 0.940 – 0.92* 3.09
EFNA1 ephrin-A1, EFNA2 ephrin-A2, EFNA3 ephrin-A3, EFNA4 ephrin-A4, EPHA6 EPH receptor A6, FGF2 fibroblast growth factor 2, NPPB
natriuretic peptide precursor B, NRP1 neuropilin 1, NTNG1 netrin G1, PEDF pigment epithelium-derived factor (serpin peptidase inhibitor, clade
Fm e m b e r1 ) ,PLXNC1 plexin C1, SEMA3D semaphorin 3D, SEMA3G semaphorin 3G, SEMA4F semaphorin 4F, UNC5D unc-5 homolog D
(C. elegans), VEGFA vascular endothelial growth factor A
*P  0.01 (not significant)
aDifferential expression is the ratio of expression levels at the macula compared with nasal/surround, expressed here as a percent value
bStandard error expressed as a percent value. The standard error of the microarray fold changes is derived from the distribution of fold changes
measured across the four specimens
cThe template used for QRT-PCR to measure differential expression between the macula and surround was derived from a different set of
specimens to that used for the macula vs. nasal comparison
}
}
}
}
}
}
}
}
}}
}
}
}
}
}
}
}
}
– 
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interest are listed in Table 6. Cadherins and immunoglob-
ulin superfamily molecules feature prominently on both
lists.
Discussion
The macula is uniquely adapted for high-acuity vision and,
probably as a result of its high level of specialization, is
vulnerable to a number of degenerative diseases that
specifically affect the macula. These include age-related
macular degeneration, Stargardt’s macular dystrophy, Best
vitelliform macular dystrophy, and macular telangiectasia.
Despite this, the gene expression profiles that characterize
the normal and healthy macula have been the subject of
relatively few investigations [20–26]. One of the more
critical adaptations of the macula appears to be the
exclusion of large retinal vessels and definition of a foveal
avascular region. This apparent constraint upon the capacity
to deliver high-volume retinal blood flow to the macula is
Fig. 5 Comparison of microarray (P<0.01, light gray/hatched bars)
and QRT-PCR (dark gray) measures of gene expression in the macula,
relative to the surround. Error bars show standard error of the mean.
Standard error for the microarray data is derived from the distribution
of fold changes measured across the four hybridized specimens. a, b
QRT-PCR performed in triplicate from the template of one human
retinal specimen at 17.5 WG (CD80, FOXG1B, SLIT2, UNC5A) or
19 WG (EGF, PTGDS), using a SYBR Green kit. c QRT-PCR
performed in triplicate from the template of two different specimens
(19 WG), using SYBR Green. d QRT-PCR performed in triplicate
from the template of three different specimens (19 WG), using
Taqman probes. The data show, in general, good consensus between
the microarray and QRT-PCR findings. Best consensus was present in
the data obtained in triplicate from three biological samples (d).
Further experiments would be needed to clarify the expression levels
of CD80 and FOXG1B; however, these genes are not presently the
subject of ongoing investigations. BAI2 brain-specific angiogenesis
inhibitor 2; CD80 CD80 molecule; EGF epidermal growth factor;
FOXG1B forkhead box G1; GUCA1C guanylate cyclase activator 1C;
OPN1MW opsin 1 (cone pigments), medium-wave-sensitive; PLXNA4
plexin A4; PTGDS prostaglandin D2 synthase 21 kDa (brain); SLIT2
slit homolog 2 (Drosophila); UNC5A unc-5 homolog A (C. elegans);
WNT5A wingless-type MMTV integration site family, member 5A
Table 4 Biological process gene clusters removed from the differen-
tial expression gene lists
Gene ontology ID Biological process
GO:0008152 Metabolic process
GO:0007049 Cell cycle
GO:0008283 Cell proliferation
GO:0051301 Cell division
GO:0050953 Sensory perception of light stimulus
GO:0009416 Response to light stimulus
GO:0019226 Transmission of nerve impulse
GO:0001505 Regulation of neurotransmitter levels
GO:0007269 Neurotransmitter secretion
GO:0007215 Glutamate signaling pathway
GO:0015813 L-glutamate transport
GO:0007214 Gamma-aminobutyric acid signaling pathway
These clusters are associated with metabolism, cell cycle and
proliferation, neurotransmission, and phototransduction, which are
processes expected to be differentially modulated in the relatively
mature macula at 19–20 WG.
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28], which carry very high metabolic load [29]. This
apparent paradox is explained by observing that the main
function of the macula is to deliver high-acuity vision, such
that both high photoreceptor/neural densities and the
absence of large retinal vessels which would shadow the
photoreceptor mosaic have arisen in the macula as a result
of evolutionary pressure. A compensatory measure appears
to be an extremely high density of microvessels in the
central macula [30], carrying with it a vulnerability to
microvascular disorders, which may underscore some of the
macula vulnerabilities, particularly with respect to immu-
nological responses. For these reasons, we have pursued
analyses of gene expression in the developing human
macula, at a stage of development when differentiation of
the principal cell components is complete but during a
period when the characteristics of the macular retinal
vasculature are still developing.
Rare tissue samples, batch effect, “expected” findings,
and QRT-PCR
A major constraint we had to overcome in this study related
to difficulties involved in obtaining retinal specimens from
different individuals of comparable ages, in suitable
condition to enable accurate biopsy of the macular region,
and of suitable quality to undertake the microarray hybrid-
izations. We also wished to avoid differences that may be
introduced by “banking” specimens, or RNA, for long
periods of time prior to hybridization. The resolution was to
process specimens in two batches—since obtaining speci-
mens in pairs is not uncommon. We made several attempts
to achieve this and finally carried out the study on two sets
of retinas, obtained several months apart, in 2006 and 2007.
The “batch analyses” reported here were conducted in order
to verify our techniques and to assure ourselves that the
two-batch approach did not confound the data prior to the
Fig. 6 KEGG molecular/reaction pathways highly represented in the
lists of macular genes of interest. Percentage values indicate the
proportion of genes that clustered to each pathway for the a macula vs.
surround and b macula vs. nasal gene lists. Human KEGG pathway ID
numbers: ABC transporters—general, hsa02010; apoptosis, hsa04210;
axon guidance, hsa04360; cell adhesion molecules, hsa04514; ECM–
receptor interaction, hsa04512; focal adhesion, hsa04510; regulation
of actin cytoskeleton, hsa04810; ribosome, hsa03010; tight junction,
hsa04530
Gene ontology ID Biological process Number of genes
Macula versus
surround
Macula versus
nasal
GO:0007154 Cell communication 250 273
GO:0065007 Biological regulation 249 272
GO:0051179 Localization 230 250
GO:0032502 Developmental process 192 236
GO:0016043 Cellular component organization
and biogenesis
160 179
GO:0007155 Cell adhesion 105 125
GO:0046903 Secretion 28 25
n/a
a Microtubule/filament-based process 20 50
GO:0050896 Response to stimulus 15 15
GO:0050817 Coagulation 10 13
Table 5 Highly represented
clustersofgenesinthedifferential
expression data after removal of
genes associated with precocious
development of the macula
GO gene ontology
aThis term is a combination of
microtubule-based process
(GO:0007017), actin filament-
based process (GO:0030029),
and intermediate filament-based
process (GO:0045103)
184 j ocul biol dis inform (2009) 2:176–189analyses to identify the macular “genes of interest.” Those
analyses are informative in that they show first that the
signal intensity from the microarrays was not significantly
different between individual microarrays or between
batches (Fig. 2). Secondly, they enabled us to visualize
the effect of “batch” on the data (Figs. 3a and 4a) and, most
importantly, that the statistical filtering available through
the Partek suite adequately addresses these differences
(Figs. 3b and 4b).
While internal quality controls showed that the hybrid-
ized microarrays were of high quality, the most important
proof of the microarray data is the comparative findings
obtained by QRT-PCR. QRT-PCR has verified the direction
of modulation of all the genes for which we have made the
comparison. In the majority of cases, levels of expression
(fold changes) detected by QRT-PCR were within the range
of the error bars obtained from the microarray data. Some
differences in levels of expression were expected because
some of the QRT-PCR runs were made using cDNA from
retinas of different ages to the ones used for the micro-
arrays. This compromise was necessary due to the
difficulties involved in obtaining fetal retinal tissues in
suitable condition to facilitate biopsy and of suitable quality
for QRT-PCR. Thus, the different fold-change measures
obtained for CD80 (Fig. 5a) and FOXG1B (Fig. 5b)b y
QRT-PCR compared with the microarrays could be due to
the use of template derived from a single retina at 17.5 WG.
The opsin gene OPN1MW was amplified using template
from two 19 WG retinas, and the relatively higher levels of
fold change detected by QRT-PCR possibly reflect higher
sensitivity of the approach.
A factor that commonly frustrates microarray studies is
the very large number of genes found to be differentially
regulated. In the present study, we found more than 3,500
genes differentially regulated in the macula. A standard
approach might be to define a level of fold change (e.g.,
twofold) and a level of significance (e.g., P<0.001) to
identify the significant genes of interest. However, such an
approach applied to our dataset would have identified
clusters of genes with roles in “cell proliferation” and “cell
division” that are differentially expressed in the macula.
Such a finding would be anticipated, since it is long
established that there is no cell proliferation or cell division
in the developing macula by midgestation, but both
processes continue in peripheral retina until about 30 WG.
One of the strengths of our study, we believe, is that with
Table 6 Twenty most highly represented clusters of proteins (Interpro) encoded by the differential gene expression data
Macula versus surround Macula versus nasal
Interpro ID Interpro protein family Number
of genes
Interpro ID Interpro protein family Number
of genes
IPR007110 Immunoglobulin-like 42 IPR007110 Immunoglobulin-like 49
IPR002126 Cadherin 42 IPR002126 Cadherin 46
IPR013783 Immunoglobulin-like fold 40 IPR013783 Immunoglobulin-like fold 46
IPR013164 Cadherin, N-terminal 39 IPR011993 Pleckstrin homology-type 46
IPR011993 Pleckstrin homology-type 35 IPR001849 Pleckstrin-like 40
IPR001849 Pleckstrin-like 29 IPR013164 Cadherin, N-terminal 39
IPR013032 EGF-like region 26 IPR013032 EGF-like region 38
IPR001680 WD40 repeat 25 IPR006210 EGF 34
IPR001611 Leucine-rich repeat 24 IPR000742 EGF-like, type 3 30
IPR011992 EF-Hand type 24 IPR011992 EF-Hand type 30
IPR001452 Src homology-3 23 IPR001452 Src homology-3 28
IPR006210 EGF 23 IPR001611 Leucine-rich repeat 28
IPR000742 EGF-like, type 3 22 IPR002048 Calcium-binding EF-hand 28
IPR015492 Protocadherin gamma 21 IPR002110 Ankyrin 25
IPR001806 Ras GTPase 20 IPR013151 Immunoglobulin 25
IPR005225 Small GTP-binding protein domain 19 IPR003598 Immunoglobulin subtype 2 23
IPR003598 Immunoglobulin subtype 2 18 IPR006209 EGF-like 22
IPR006209 EGF-like 17 IPR015492 Protocadherin gamma 21
IPR003591 Leucine-rich repeat, typical subtype 16 IPR013098 Immunoglobulin I-set 20
IPR001478 PDZ/DHR/GLGF 16 IPR003591 Leucine-rich repeat, typical subtype 20
Cadherins and proteins that contain immunoglobulin (Ig) domains form the largest clusters of proteins encoded by the differentially expressed
genes
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be differentially expressed (downregulated) in the macula,
we could (1) use this information to gauge the levels of fold
change that might be expected in significant gene clusters
and (2) simplify the further analysis by eliminating these
categories. Furthermore, at an early stage of the verification
process, we ran QRT-PCR for genes that we expected to be
upregulated in the macula—because of its more advanced
state of differentiation—and compared the findings. Two
such genes are shown in Fig. 5c.
Biological process clustering of the gene lists, after
removal of expected genes, showed that a large number of
genes with roles in “cell communication” and “regulatory
processes” are differentially regulated in the macula during
development. More specific insight into these families
was obtained using KEGG pathway and InterPro gene
clustering, showing that genes involved in regulation of
the actin cytoskeleton and genes involved in cell adhe-
sion are highly represented in the list of macular genes
of interest.
Significance of the different clusters/gene families
Axon and vascular guidance genes
We have addressed the significance of the differential
expression of axon guidance genes previously [1] and the
role that one of these (EPHA6) may play in development of
the retinal projections, and vascular growth in the retina is
the subject of a separate study [19]. There is growing
consensus that axon guidance molecules provide guidance
cues to developing vasculature [31]. Many guidance factors
act through repellent mechanisms that drive cells express-
ing binding partners away from each other, along gradients
of ligand and/or receptor expression, and it has been shown
that in the developing visual system relative levels of ligand
and receptor expression guide outgrowing axons, rather
than levels of expression per se [32]. We propose that the
group of 25 “axon guidance factors” on our list of macular
genes of interest includes genes that regulate both axon and
vascular patterning. Our hypothesis is that axon guidance
genes mediate axon guidance out of the retina, which takes
place between about 8 and 25 WG, and regulate the growth
of vessels into the macula between about 15 and 30 WG. In
both instances, we propose that the regulatory mechanism
is largely repellent, serving initially to guide axons away
from the macula and subsequently to slow retinal vessel
growth into the macula and prevent large vessels from
traversing the central macula and fovea. Our findings
suggest, therefore, that the reduced density of large vessels
evident in the macula has coevolved with mechanisms that
guide axons away from the macula, keeping the nerve fiber
layer of the macula region relatively thin, and favoring a
clear optical path for light directed at the macular photo-
receptor array.
Regulation of the actin cytoskeleton
Growth cone guidance is controlled by cues that influence
actin cytoskeletal dynamics [33]. These regulatory genes
function at the molecular level to adjust actin filament archi-
tecture within axonal growth cones and, with the assistance
of microtubules, change the direction of axon growth [34,
35]. It is also likely that they assist with vascular guidance,
given the similarity in the basic guidance mechanism of
vasculature and neuronal growth cones [36]. A high
representation of genes associated with regulation of actin
cytoskeleton in the macula suggests an active and spatially
regulated guidance function at midgestation. Because the
majority of ganglion cells in the macula would have axons
that have already reached the optic disk by midgestation, it
seems likely that these cytoskeletal regulatory genes are
mediating the development or refinement of neural and
glial cell processes in the sample region or at the growing
tips of retinal blood vessels on the peripheral margin of the
macula biopsy.
Cell adhesion molecules
The functional significance of differential expression of cell
adhesion molecules (CAMs) in the developing macula at
midgestation is not clear. One possibility is that CAMs have
a role in the formation and early maintenance of retinal
circuits at this stage of development. In addition, we know
that at midgestation retinal cells are displaced centripetally
toward the incipient fovea. Prior to formation of the foveal
depression at 25–27 WG, there is an increase in numerical
density of cells in all retinal layers in the macula that results
in a thickening of the retinal profile [15, 37–39], despite the
opposing effect of retinal stretch which tends to spread cells
across the retina as it grows [40]. One possible role for the
CAMs may be to mediate adhesion of adjacent cells,
resisting the effects of retinal stretch. The macula biopsy
region may also include on its margin some axons from
peripheral retina still navigating the optic nerve head and
proximal optic nerve. It is possible, therefore, that to some
degree the high levels of CAM expression we detect in the
macula is also associated with axon outgrowth. During this
phase, axons grow parallel to the retinal surface, along the
inner limiting membrane formed by Müller cell processes,
which are thought to have a role in guidance [41]. Once the
pioneering axons have reached the choroidal fissure, which
later forms the optic disk, future axons can also use the
preformed “pioneer axons” as a guide, mediated by CAMs.
There are five main classes of CAMs, including cadherins,
integrins, and immunoglobulin superfamily CAMs. The
186 j ocul biol dis inform (2009) 2:176–189cadherins and integrins are highly represented among our
macular genes of interest, while immunoglobulin-like genes
appear as representatives of the immunoglobulin superfamily.
Cadherins Cadherins are calcium-dependent, homophilic
cell–cell adhesion molecules that regulate a range of
morphogenetic processes, through association with adhe-
rens junctions and the actin cytoskeleton [42, 43]. Six
classic cadherins are significantly differentially regulated in
the macula—cadherins 2 and 6, which are downregulated,
and 8, 12, 13, and 18, which are upregulated. One of these,
cadherin-2 or NCAD, mediates tracking of retinal axons
along pathways established by pioneer axons in the
developing optic nerve [44, 45], but little is known about
the role of other cadherins in the developing vertebrate
visual system. For example, cadherin 6 expression has been
detected in fetal zebra fish retina and is thought to contribute
to retinal cell development [46], but little work has been
done on the remaining cadherins in the retina (cadherin 8,
12, 13, 18) beyond measures of gene expression [47–50].
While cadherins are important contributors to central
nervous system (CNS) development, there is a caveat to
their high representation in the protein group clustering. A
large number of protocadherins, a less well-studied sub-
family of cadherins prominent in the central nervous system
[43], are represented in the differential expression data.
However, their prominence is exaggerated because the inter-
rogated region is in the conserved cytoplasmic 3-exon region
that is shared by all 22 members of the gamma subset of
protocadherins [51] and is represented by only four probe
sets (205717_x_at, 209079_x_at, 211066_x_at, 215836_
s_at). Thus, all gamma protocadherin genes that appear in
the InterPro cadherin cluster were unevenly interrogated by
a small number of probe sets. The one probe set that
interrogated a region outside the conserved region produced
significant differential expression in the macula (probe set
1552735_at), interrogating a protocadherin gamma A4
(PCDHGA4) isoform precursor. Thirteen members of the
alpha subset of protocadherins were also present in the
InterPro cadherin cluster, but all 13 genes were interrogated
by only one probe set (223435_s_at) probing the conserved
cytoplasmic 3-exon region.
Integrins Collagen genes as well as others associated with
basal lamina, such as laminin [52], or extracellular matrix
interacting proteins/proteoglycans, such as the CD44 family
of isoforms [53], are prevalent in the KEGG pathway
clusters “focal adhesion” and “ECM–receptor interaction.”
These pathways are associated with cell–cell interaction
and may be associated with extension of cell processes and
the formation of cell–cell contacts or in neuronal cell
packing, as alluded to above. Integrins are expressed by
Müller cells [54] although little is known about their
functions in this context. The differentially expressed genes
include integrin subunits α2, α3, α6, β1, and β8, combina-
tions of which include heterodimers that are receptors for
laminin [55, 56].
Immunoglobulin superfamily Immunoglobulin superfamily
(IgSF) CAMs contain at least one Ig-like domain, constitute
the largest family of CAMs, and are widely expressed in the
developing and mature nervous system. Many also contain
fibronectin type III (FNIII) repeats and are categorized
based on domain number and organization [57]. The
structure, function, and categories of IgSF CAMs are
reviewed in Brümmendorf and Rathjen [58] and Walsh
and Doherty [59]. IgSF CAMs that showed significant
differential expression in the macula included DSCAM,
CD47, CD58, CD80, EMB, as well as members of the
subfamilies of contactins, ICAMs, NCAMs, IgLONs, and
L1. The microarray data correctly reflect what is known
about NCAM, an important and well-characterized mole-
cule involved in cell growth and morphogenesis in the CNS
[59]. A 21% downregulation was measured in the macula,
and this is likely because of localized NCAM expression in
type 1B astrocytes in fetal optic nerve head [60, 61] and
which are likely to carry this expression into the retina,
along with the retinal vessels, which are fewer in number in
the macula. Given the large size and diverse range of
functions of IgSF CAMs other than cell adhesion, such as
synapse plasticity and axonal growth, guidance, and
fasciculation, further investigation of the role these mole-
cules play in retinal development is warranted.
Resource for emerging gene linkage studies
Genome-wide linkage or association studies seek to identify
polymorphisms in genes that may be the root cause of a
disease process or which may cluster with a few or several
other genes and/or environmental factors to cause disease.
Outstanding here are the linkage analyses associating a
single nucleotide polymorphism in the gene encoding
complement factor H with risk of developing age-related
macular degeneration [62–64]. In that case, a gene that is
widely expressed in a variety of tissues and which mediates
a fundamental role in the innate immune response was
implicated in the disease process. A large number of similar
association studies are currently in progress in a variety of
areas, which seek to identify genes associated with a range
of ocular disorders, including myopia and glaucoma. Gene
expression in the primate retina has not been widely
investigated, and since the macula is a retinal specialization
not present in the popular mouse models, data from this study
provide a valuable resource, where the retinal expression
patterns of disease-associated genes are not known.
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